Trials / Conditions / Histiocytic Sarcoma
Histiocytic Sarcoma
5 registered clinical trials studyying Histiocytic Sarcoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810 | Mayo Clinic | Phase 1 |
| Recruiting | Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders NCT04079179 | Carl Allen | Phase 2 |
| Suspended | Pembrolizumab in Neoplasms or Lymphomas NCT03316573 | Dana-Farber Cancer Institute | Phase 2 |
| Active Not Recruiting | Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanc NCT03155620 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Ex NCT03651375 | Maria Sklodowska-Curie National Research Institute of Oncology | Phase 2 |